EMPIRE STATE REALTY TRUST-A (ESRT) Fundamental Analysis & Valuation

NYSE:ESRTUS2921041065

Current stock price

5.53 USD
+0.05 (+0.91%)
Last:

This ESRT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ESRT Profitability Analysis

1.1 Basic Checks

  • ESRT had positive earnings in the past year.
  • ESRT had a positive operating cash flow in the past year.
  • Of the past 5 years ESRT 4 years were profitable.
  • In the past 5 years ESRT always reported a positive cash flow from operatings.
ESRT Yearly Net Income VS EBIT VS OCF VS FCFESRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • ESRT has a Return On Assets of 0.97%. This is comparable to the rest of the industry: ESRT outperforms 54.92% of its industry peers.
  • ESRT's Return On Equity of 3.98% is fine compared to the rest of the industry. ESRT outperforms 60.66% of its industry peers.
  • ESRT has a Return On Invested Capital (2.50%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ESRT is in line with the industry average of 3.12%.
Industry RankSector Rank
ROA 0.97%
ROE 3.98%
ROIC 2.5%
ROA(3y)1.06%
ROA(5y)0.76%
ROE(3y)4.43%
ROE(5y)3.19%
ROIC(3y)2.75%
ROIC(5y)2.48%
ESRT Yearly ROA, ROE, ROICESRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4

1.3 Margins

  • With a Profit Margin value of 5.65%, ESRT perfoms like the industry average, outperforming 55.74% of the companies in the same industry.
  • ESRT's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 17.66%, ESRT perfoms like the industry average, outperforming 42.62% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ESRT has grown nicely.
  • ESRT has a worse Gross Margin (53.70%) than 75.41% of its industry peers.
  • In the last couple of years the Gross Margin of ESRT has remained more or less at the same level.
Industry RankSector Rank
OM 17.66%
PM (TTM) 5.65%
GM 53.7%
OM growth 3Y0.36%
OM growth 5Y10.63%
PM growth 3Y4.1%
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y-0.01%
ESRT Yearly Profit, Operating, Gross MarginsESRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

4

2. ESRT Health Analysis

2.1 Basic Checks

  • ESRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ESRT has more shares outstanding
  • ESRT has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ESRT has been reduced compared to a year ago.
ESRT Yearly Shares OutstandingESRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ESRT Yearly Total Debt VS Total AssetsESRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • ESRT has an Altman-Z score of 0.49. This is a bad value and indicates that ESRT is not financially healthy and even has some risk of bankruptcy.
  • ESRT's Altman-Z score of 0.49 is in line compared to the rest of the industry. ESRT outperforms 50.00% of its industry peers.
  • ESRT has a Debt/Equity ratio of 2.18. This is a high value indicating a heavy dependency on external financing.
  • ESRT has a Debt to Equity ratio of 2.18. This is in the lower half of the industry: ESRT underperforms 70.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.18
Debt/FCF N/A
Altman-Z 0.49
ROIC/WACC0.43
WACC5.87%
ESRT Yearly LT Debt VS Equity VS FCFESRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • ESRT has a Current Ratio of 2.34. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 2.34, ESRT belongs to the best of the industry, outperforming 90.16% of the companies in the same industry.
  • ESRT has a Quick Ratio of 2.34. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • ESRT has a Quick ratio of 2.34. This is amongst the best in the industry. ESRT outperforms 90.16% of its industry peers.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 2.34
ESRT Yearly Current Assets VS Current LiabilitesESRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

4

3. ESRT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 38.10% over the past year.
  • ESRT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 57.42% yearly.
  • ESRT shows a small growth in Revenue. In the last year, the Revenue has grown by 0.05%.
  • The Revenue has been growing slightly by 4.75% on average over the past years.
EPS 1Y (TTM)38.1%
EPS 3Y34.2%
EPS 5Y57.42%
EPS Q2Q%-4.17%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y1.86%
Revenue growth 5Y4.75%
Sales Q2Q%2.96%

3.2 Future

  • ESRT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -39.35% yearly.
  • Based on estimates for the next years, ESRT will show a small growth in Revenue. The Revenue will grow by 2.24% on average per year.
EPS Next Y-92.97%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
EPS Next 5Y-39.35%
Revenue Next Year2.89%
Revenue Next 2Y2.2%
Revenue Next 3Y1.81%
Revenue Next 5Y2.24%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ESRT Yearly Revenue VS EstimatesESRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ESRT Yearly EPS VS EstimatesESRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6 0.8

4

4. ESRT Valuation Analysis

4.1 Price/Earnings Ratio

  • ESRT is valuated cheaply with a Price/Earnings ratio of 6.36.
  • Based on the Price/Earnings ratio, ESRT is valued cheaply inside the industry as 99.18% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.47, ESRT is valued rather cheaply.
  • ESRT is valuated quite expensively with a Price/Forward Earnings ratio of 90.36.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ESRT is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.62, ESRT is valued quite expensively.
Industry RankSector Rank
PE 6.36
Fwd PE 90.36
ESRT Price Earnings VS Forward Price EarningsESRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • ESRT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ESRT is cheaper than 86.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.61
ESRT Per share dataESRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • ESRT's earnings are expected to decrease with -61.15% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.11
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%

3

5. ESRT Dividend Analysis

5.1 Amount

  • ESRT has a Yearly Dividend Yield of 2.56%.
  • Compared to an average industry Dividend Yield of 7.46, ESRT's dividend is way lower than its industry peers. On top of this 82.79% of the companies listed in the same industry pay a better dividend than ESRT!
  • Compared to an average S&P500 Dividend Yield of 1.81, ESRT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.56%

5.2 History

  • The dividend of ESRT decreases each year by -6.73%.
  • ESRT has paid a dividend for at least 10 years, which is a reliable track record.
  • ESRT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-6.73%
Div Incr Years0
Div Non Decr Years4
ESRT Yearly Dividends per shareESRT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

5.3 Sustainability

  • ESRT pays out 64.35% of its income as dividend. This is not a sustainable payout ratio.
  • ESRT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP64.35%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
ESRT Yearly Income VS Free CF VS DividendESRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M
ESRT Dividend Payout.ESRT Dividend Payout, showing the Payout Ratio.ESRT Dividend Payout.PayoutRetained Earnings

ESRT Fundamentals: All Metrics, Ratios and Statistics

EMPIRE STATE REALTY TRUST-A

NYSE:ESRT (4/24/2026, 1:43:08 PM)

5.53

+0.05 (+0.91%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-17
Earnings (Next)04-29
Inst Owners102.42%
Inst Owner Change-0.03%
Ins Owners0.09%
Ins Owner Change0.04%
Market Cap945.96M
Revenue(TTM)768.27M
Net Income(TTM)43.40M
Analysts75
Price Target7.41 (34%)
Short Float %7.75%
Short Ratio7.75
Dividend
Industry RankSector Rank
Dividend Yield 2.56%
Yearly Dividend0.17
Dividend Growth(5Y)-6.73%
DP64.35%
Div Incr Years0
Div Non Decr Years4
Ex-Date03-13
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.36%
PT rev (3m)-8.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.36
Fwd PE 90.36
P/S 1.23
P/FCF N/A
P/OCF 3.8
P/B 0.87
P/tB 3.23
EV/EBITDA 9.61
EPS(TTM)0.87
EY15.73%
EPS(NY)0.06
Fwd EY1.11%
FCF(TTM)-2.11
FCFYN/A
OCF(TTM)1.46
OCFY26.33%
SpS4.49
BVpS6.37
TBVpS1.71
PEG (NY)N/A
PEG (5Y)0.11
Graham Number11.1681 (101.95%)
Profitability
Industry RankSector Rank
ROA 0.97%
ROE 3.98%
ROCE 3.16%
ROIC 2.5%
ROICexc 2.58%
ROICexgc 3.19%
OM 17.66%
PM (TTM) 5.65%
GM 53.7%
FCFM N/A
ROA(3y)1.06%
ROA(5y)0.76%
ROE(3y)4.43%
ROE(5y)3.19%
ROIC(3y)2.75%
ROIC(5y)2.48%
ROICexc(3y)2.96%
ROICexc(5y)2.68%
ROICexgc(3y)3.73%
ROICexgc(5y)3.4%
ROCE(3y)3.48%
ROCE(5y)3.14%
ROICexgc growth 3Y-2.22%
ROICexgc growth 5Y10.35%
ROICexc growth 3Y-1.13%
ROICexc growth 5Y11.75%
OM growth 3Y0.36%
OM growth 5Y10.63%
PM growth 3Y4.1%
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 2.18
Debt/FCF N/A
Debt/EBITDA 7.18
Cap/Depr 313.47%
Cap/Sales 79.47%
Interest Coverage 1.45
Cash Conversion 75.38%
Profit Quality N/A
Current Ratio 2.34
Quick Ratio 2.34
Altman-Z 0.49
F-Score6
WACC5.87%
ROIC/WACC0.43
Cap/Depr(3y)200.4%
Cap/Depr(5y)163.62%
Cap/Sales(3y)50.04%
Cap/Sales(5y)43.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.1%
EPS 3Y34.2%
EPS 5Y57.42%
EPS Q2Q%-4.17%
EPS Next Y-92.97%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
EPS Next 5Y-39.35%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y1.86%
Revenue growth 5Y4.75%
Sales Q2Q%2.96%
Revenue Next Year2.89%
Revenue Next 2Y2.2%
Revenue Next 3Y1.81%
Revenue Next 5Y2.24%
EBIT growth 1Y-14.53%
EBIT growth 3Y2.22%
EBIT growth 5Y15.89%
EBIT Next Year144.54%
EBIT Next 3Y36.3%
EBIT Next 5Y22.27%
FCF growth 1Y-231.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.54%
OCF growth 3Y5.65%
OCF growth 5Y6.44%

EMPIRE STATE REALTY TRUST-A / ESRT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EMPIRE STATE REALTY TRUST-A?

ChartMill assigns a fundamental rating of 4 / 10 to ESRT.


Can you provide the valuation status for EMPIRE STATE REALTY TRUST-A?

ChartMill assigns a valuation rating of 4 / 10 to EMPIRE STATE REALTY TRUST-A (ESRT). This can be considered as Fairly Valued.


Can you provide the profitability details for EMPIRE STATE REALTY TRUST-A?

EMPIRE STATE REALTY TRUST-A (ESRT) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for ESRT stock?

The Earnings per Share (EPS) of EMPIRE STATE REALTY TRUST-A (ESRT) is expected to decline by -92.97% in the next year.


How sustainable is the dividend of EMPIRE STATE REALTY TRUST-A (ESRT) stock?

The dividend rating of EMPIRE STATE REALTY TRUST-A (ESRT) is 3 / 10 and the dividend payout ratio is 64.35%.